Slalom Welcomes Denis Gassmann as President and Country Leader for Germany
Currently in Munich, the global consulting firm plans to expand to Frankfurt, Dusseldorf, and Berlin
Munich – October 4, 2022 – Slalom, the global business and technology consulting company, today announced Denis Gassmann has joined as President & Country Leader of its business in Germany. His arrival comes shortly after Slalom opened offices in Munich.
With more than 25 years of experience in IT and technology & digital transformation, Denis joins Slalom from Accenture. In his two decades with his prior company, he held many leadership positions, most recently Managing Director - Industry Platforms Lead, Europe.
“All over the world, Slalom is guided by dedication to living our values and providing unmatched customer focus,” says John Tobin, Slalom co-founder and Executive President, EMEA & APAC. “Denis has a reputation for building high-performing teams and bringing enormous passion for how technology can transform business. We are delighted to welcome him to our global leadership team.”
Slalom offers consulting and advisory services to local German clients in a range of industries, includingLife Sciences, Media and Communications, Technology, Manufacturing, and Financial Services.
“Germany has the fourth largest economy in the world and its needs are rapidly expanding. Slalom has a unique people-first approach and expertise in using tech solutions to help our clients innovate, and we find our success by recruiting strong teams and delivering solutions to clients in new ways,” said Denis.
Denis is taking over from Heather Sneddon, the interim market leader for Slalom Germany. Slalom expects to hire up to 75 employees in its Munich office by the end of the year and plans to expand to other regional locations including Frankfurt, Dusseldorf, and Berlin.
Slalom is a purpose-led, global business and technology consulting company. From strategy to implementation, our approach is fiercely human. In six countries and 43 markets, we deeply understand our customers—and their customers—to deliver practical, end-to-end solutions that drive meaningful impact. Backed by close partnerships with over 400 leading technology providers, our 13,000+ strong team helps people and organizations dream bigger, move faster, and build better tomorrows for all. We’re honored to be consistently recognized as a great place to work, including being one of Fortune’s 100 Best Companies to Work For seven years running. Learn more atslalom.com.
Press Contact: P. Mashegwama
As wholly owned subsidiary of dpa, news aktuell provides business and organizations with effective access to media and consumers. Via the smart tools ots and zimpel, PR content accesses all media formats, including classical print, high click-rate online portals and social networks. In addition, news aktuell publishes all its customers’ PR content on www.presseportal.de, one of the PR portals with the greatest reach in Germany. By this means, all the relevant multipliers are reached globally, from editors, via digital influencers right up to specialist bloggers and interested consumers. news aktuell has been on the market since 1989. The company, with a staff complement of more than 135, has its headquarters in Hamburg. Other offices are in Berlin, Dusseldorf, Frankfurt und Munich.
Följ news aktuell GmbH
Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.
Senaste pressmeddelandena från news aktuell GmbH
Flu tests from R-Biopharm also detect new virus variants25.11.2022 10:46:20 CET | Press release
Darmstadt, November 25, 2022 – The flu season has begun and different virus variants are also circulating in Germany. With the flu tests from biotechnology company R-Biopharm, patients quickly have certainty: Its RIDA®GENE Flu assays also reliably detect the two novel variants. The company made the announcement with regard to influenza A H1N1pdm09, which is circulating primarily in the United Kingdom, and the H3N2 subtype, which was rampant in Denmark in the spring and is currently dominating influenza activity in Germany. "Mutations in the target gene (MP gene) can affect the diagnostic performance of influenza screening assays, producing false-negative test results," explains Dr. Andreas Simons, Head of Product Management at R-Biopharm. " Alignments of the detection systems we used with the described sequences of the two novel virus variants showed no mismatches. Their reliable detection is not affected by the described mutations." This means laboratories can continue to reliably con
Saudi Industrial City Giga-Project Adds New Direct Investments and Contracts to its Total Investments of 26,7 billion USD24.11.2022 08:32:19 CET | Press release
New investment agreements will contribute to food sustainability in the country and further develop the advanced living environment for Jazan City for Primary and Downstream Industries
THE HIGH-PERFORMANCE SINGLE-SEATER 777 HYPERCAR IS BORN IN MONZA22.11.2022 11:05:00 CET | Press release
The 777 hypercar is a new Italian hypercar born of the excellent partnership with Andrea Levy, Dallara, and Gibson, built from technology used in motorsports and all informations and images are on www.777hypercar.com. 777 hypercar is built by 777 Motors, the car manufacturer based in the Autodromo Nazionale Monza and founded by Andrea Levy, an entrepreneur, car collector, racing driver, and president of MIMO Milano Monza Motorshow. The 777 hypercar project will be presented on November 22, limited to just 7 units, each of which will cost 7 million euros. 777 hypercar is at the top for performance thanks to an FIA-homologated carbon monocoque developed by Dallara, which generate an incredible downforce of 2,100 kg at a speed of 370 km/h, an extremely low weight of 900 kg, and a lateral acceleration from 3.5 to 4 g that keeps the car glued to the asphalt, giving an incredible estimate lap time of just 1 minute and 33 seconds in the Monza Circuit. The engine is a naturally aspirated V8, 4
Janneke van der Kamp joins Grünenthal as new Chief Commercial Officer22.11.2022 11:01:42 CET | Press release
AACHEN, Germany, 22 November 2022 –Grünenthal today announced that Janneke van der Kamp will join Grünenthal as the new Chief Commercial Officer (CCO), effective 1 March 2023. Janneke van der Kamp joins Grünenthal from Novartis, where she most recently served as Head of Pharma Region Europe. The Dutch native brings broad experience in the pharmaceutical industry from several roles including General Manager, Global Neurosciences Franchise Head and Global Head of Product and Portfolio Strategy for the entire Novartis Pharma portfolio. She worked closely with Research & Development and the Licensing & Acquisitions teams to strengthen the company’s pipeline. Janneke van der Kamp has vast expertise in launching and growing key brands across several disease areas. She is a studied chemist and holds an MBA from INSEAD. As CCO of Grünenthal, Janneke van der Kamp will be responsible for the entire Global Commercial Organisation and serve as a member of the Corporate Executive Board. Her focus w
BMW Group secures CO2-reduced steel for global production network16.11.2022 16:04:20 CET | Pressmeddelande
Lower CO2 emissions for over one third of global steel purchasing
I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.Besök vårt pressrum